These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10808822)

  • 21. How insulin analogues can benefit patients.
    Dokken BB
    Nurse Pract; 2013 Feb; 38(2):44-8. PubMed ID: 23344228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival after myocardial infarction in patients with type 2 diabetes.
    Zia S; Hasan ZU
    J Pak Med Assoc; 2004 Feb; 54(2):73-80. PubMed ID: 15134207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe hypertriglyceridaemia in Type 2 diabetes mellitus: beneficial effect of continuous insulin infusion.
    Henderson SR; Maitland R; Mustafa OG; Miell J; Crook MA; Kottegoda SR
    QJM; 2013 Apr; 106(4):355-9. PubMed ID: 23417910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin infusion for critically ill patients].
    Skeie S; Søreide E; Cooper J
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2378-81. PubMed ID: 17895943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hyperglycemia in adult-onset diabetes mellitus].
    Yki-Järvinen H
    Duodecim; 1999; 115(10):1155-64. PubMed ID: 11877855
    [No Abstract]   [Full Text] [Related]  

  • 26. [Glycemic control in the coronary care unit: prognostic value and new therapeutic strategies].
    Madonna R; Colella ME; De Caterina R
    G Ital Cardiol (Rome); 2008 Sep; 9(9):603-14. PubMed ID: 18783081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.
    Erdmann E; Dormandy JA; Charbonnel B; Massi-Benedetti M; Moules IK; Skene AM;
    J Am Coll Cardiol; 2007 May; 49(17):1772-80. PubMed ID: 17466227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperglycemia in the intensive care unit: in the course of a myocardial infarction in the diabetic patient].
    Bossu C
    Ann Endocrinol (Paris); 2003 Dec; 64(6):488-9. PubMed ID: 15080162
    [No Abstract]   [Full Text] [Related]  

  • 29. Improving post-prandial control with Humalog and Humalog mixtures.
    Lüddeke HJ
    Int J Clin Pract Suppl; 2000 Sep; (112):23-8. PubMed ID: 11064948
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperglycaemia and coronary heart disease: the meta picture.
    Mazzone T
    Lancet; 2009 May; 373(9677):1737-8. PubMed ID: 19465212
    [No Abstract]   [Full Text] [Related]  

  • 31. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
    Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
    Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials.
    Pittas AG; Siegel RD; Lau J
    Arch Intern Med; 2004 Oct; 164(18):2005-11. PubMed ID: 15477435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive insulin treatment of diabetic patients with myocardial infarction is highly cost-effective.
    Hildebrandt P
    Eur Heart J; 2000 May; 21(9):700-2. PubMed ID: 10739721
    [No Abstract]   [Full Text] [Related]  

  • 34. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.
    Ceriello A; Zarich SW; Testa R
    J Am Coll Cardiol; 2009 Feb; 53(5 Suppl):S9-13. PubMed ID: 19179217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes.
    Danne T; Bangstad HJ; Deeb L; Jarosz-Chobot P; Mungaie L; Saboo B; Urakami T; Battelino T; Hanas R;
    Pediatr Diabetes; 2014 Sep; 15 Suppl 20():115-34. PubMed ID: 25182312
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ; Montgomery PA
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in diabetes care and management.
    Figge J; Figge HL
    Clin Orthop Relat Res; 1993 Nov; (296):31-6. PubMed ID: 8222444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.